Newsroom | 13500 results
Sorted by: Latest
-
MedX Announces Proposed Non-Brokered Private Placement to Raise up to $2,500,000 and Stock Option Grants
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that it is proposing to raise up to $2,500,000 by way of a Non-Brokered Private Placement of up to 33,333,334 Units at $0.075 per Unit (“Unit”). Each Unit will be comprised of One (1) fully paid common share and One-half (1/2) of a Share Purchase Warrant; each whole Share Purchase Warrants (“Warrant(s)”) will be exercisable to purchase One (1) further Common Share at the price...
-
The Vascular Care Group Welcomes Dr. Scott James as Newest Physician Partner
PLYMOUTH, Mass.--(BUSINESS WIRE)--The Vascular Care Group Welcomes Dr. Scott James as Newest Physician Partner...
-
American College of Diabetology Announces Formal Taxonomy Classification for Diabetology
WASHINGTON--(BUSINESS WIRE)--The American College of Diabetology (ACD) announced that Diabetology has received formal recognition through the assignment of a unique taxonomy classification. This marks a historic milestone for the field, affirming the specialized expertise of physicians who focus exclusively or primarily on diabetes care. “This recognition is about formally naming a field that already exists in practice — one where clinicians devote their careers to comprehensive, patient-center...
-
Abra Dental Expands Access to Quality Care with New Paterson, NJ Office
PATERSON, N.J.--(BUSINESS WIRE)--Abra Dental, a leading provider of family and pediatric dental care, proudly announces the grand opening of its seventh location at 370 Broadway in Paterson, New Jersey. The new office is now open and accepting new patients from Paterson and the surrounding communities. With a commitment to providing high-quality, accessible dental care, Abra Dental’s Paterson office features state-of-the-art technology and a compassionate, multilingual team skilled in serving p...
-
Geneoscopy’s New FDA-Approved Stool Collection Method Simplifies At-Home Colorectal Cancer Screening
ST. LOUIS--(BUSINESS WIRE)--Geneoscopy has received FDA approval to streamline the stool collection process for ColoSense®, its RNA-based colorectal cancer screening test....
-
IntelePeer Emerges as AI Partner of Choice for PE-Backed Companies, Driving Value Creation in Healthcare
DANIA BEACH, Fla.--(BUSINESS WIRE)--IntelePeer, the leading end-to-end Conversational AI platform, today announced continued momentum among private equity (PE) firms seeking to drive operational efficiency and margin expansion across their healthcare portfolios. With 26 healthcare customers backed by 33 PE firms, IntelePeer is rapidly emerging as a strategic enabler for PE-backed companies navigating rising labor costs, debt pressures, and the urgent need for digital transformation. “Private eq...
-
Planet DDS Achieves 28% Year-Over-Year Growth, Solidifying Leadership in the Dental Software Revolution
IRVINE, Calif.--(BUSINESS WIRE)--The dental industry’s rapid consolidation is creating an urgent need for technology standardization. Dental support organizations (DSOs) acquiring multiple practices face a costly reality: fragmented software creates operational inefficiencies, drives up overhead, and reduces enterprise value at exit. Leading the industry-wide transformation to standardized, cloud-based solutions is Planet DDS, which today announced mid-year results highlighting its position as...
-
Innovaccer and AMGA Announce Strategic Partnership to Advance Integrated Healthcare Delivery for Medical Groups Nationwide
SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, today announced a strategic partnership with the American Medical Group Association (AMGA), a trusted trade association representing more than 400 of the nation’s leading health systems and medical groups. Through this collaboration, Innovaccer will support AMGA’s mission by enabling its members to access cutting-edge innovation, influence the adoption of emerging technologies, and shape the future of care deliver...
-
DocGo to Announce Second Quarter 2025 Results on Thursday, August 7, 2025
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the Company will release its financial results for the second quarter ended June 30, 2025 after the markets close on Thursday, August 7, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, August 7, 2025 5:...
-
MeMed Completes Development of First-Ever Fingerstick Host-Response Test for Rapid Differentiation of Bacterial and Viral Infections
ANDOVER, Mass. & HAIFA, Israel--(BUSINESS WIRE)--MeMed BV Flex test differentiates between bacterial and viral infection in 15 minutes using only a few drops of capillary blood from a finger prick....